Gastric cancer (GC) remains the third most common cause of cancer death worldwide, with
limited therapeutic strategies available. With the advent of next-generation sequencing and …

Gastric cancer (GC) is the third leading cause of cancer mortality worldwide. Although
surgical resection is a potentially curative approach for localized cases of GC, most cases of …

Gastric cancer (GC) is one of the deadliest malignancies in the world. Currently, clinical
treatment decisions are mostly made based on the extent of the tumor and its anatomy, such …

Gastric cancer imposes a considerable health burden around the globe despite its declining
incidence. The disease is often diagnosed in advanced stages and is associated with a poor …

Gastric cancer is the second leading cause of cancer-related deaths worldwide.
Conventional cytotoxic chemotherapy has limited efficacy for metastatic gastric cancer, with …

Simple Summary During the last several years, gastric cancer has been extensively studied
on the molecular level and distinct molecular subtypes have been defined accordingly …

Advancement in the field of cancer genomics is revolutionizing the molecular
characterization of a wide variety of different cancers. Recent application of large-scale, next …

Gastric cancer is a major source of global cancer mortality with limited treatment options and
poor patient survival. As our molecular understanding of gastric cancer improves, we are …

Gastric cancer (GC) is a highly aggressive and life-threatening malignancy. Even with
radical surgical removal and front-line chemotherapy, more than half of GCs locally relapse …

Gastric cancer is a heterogeneous disease with almost one million new cases occurring
annually worldwide. The year 2012 saw important successes and failures in gastric cancer …